NewEdge Advisors’s Sarepta Therapeutics SRPT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $3.49K | Hold |
204
| – | – | ﹤0.01% | 3494 |
|
|
2025
Q1 | $13K | Hold |
204
| – | – | ﹤0.01% | 3002 |
|
|
2024
Q4 | $24.8K | Sell |
204
-8,726
| -98% | -$1.06M | ﹤0.01% | 2750 |
|
|
2024
Q3 | $1.12M | Buy |
8,930
+3,339
| +60% | +$417K | 0.01% | 1050 |
|
|
2024
Q2 | $883K | Sell |
5,591
-1,363
| -20% | -$215K | 0.01% | 1130 |
|
|
2024
Q1 | $900K | Buy |
6,954
+6,582
| +1,769% | +$852K | 0.01% | 1048 |
|
|
2023
Q4 | $35.9K | Buy |
372
+45
| +14% | +$4.34K | ﹤0.01% | 2335 |
|
|
2023
Q3 | $39.6K | Hold |
327
| – | – | ﹤0.01% | 2160 |
|
|
2023
Q2 | $37.4K | Sell |
327
-8
| -2% | -$916 | ﹤0.01% | 2178 |
|
|
2023
Q1 | $46.2K | Sell |
335
-11
| -3% | -$1.52K | ﹤0.01% | 2037 |
|
|
2022
Q4 | $45 | Buy |
+346
| New | +$45 | ﹤0.01% | 3489 |
|
|
2021
Q1 | – | Sell |
-1,250
| Closed | -$213K | – | 1107 |
|
|
2020
Q4 | $213K | Buy |
+1,250
| New | +$213K | 0.01% | 879 |
|
|
2020
Q3 | – | Sell |
-1,542
| Closed | -$247K | – | 974 |
|
|
2020
Q2 | $247K | Buy |
+1,542
| New | +$247K | 0.01% | 723 |
|
|
2018
Q4 | – | Sell |
-1,369
| Closed | -$221K | – | 705 |
|
|
2018
Q3 | $221K | Buy |
+1,369
| New | +$221K | 0.02% | 587 |
|